Please provide your email address to receive an email when new articles are posted on . HPV-based vs. cytology-based screening was tied to lower risks for invasive cervical cancer. Adverse events were ...

The test could serve as an alternative in cervical cancer screening, cytology, according to a new study. Certain types of ...

In May 2024, the Food and Drug Administration (FDA) approved two new cervical screening tests for detecting human papillomavirus (HPV), which causes almost all cervical cancers. Both allow individuals ...

Menstrual blood HPV testing may offer a non-invasive option for cervical cancer screening with strong diagnostic accuracy. Learn more about the study.

The FDA has expanded the approval of Hologic’s Aptima human papillomavirus (HPV) assay for clinician-collected primary ...

Objective To compare the diagnostic accuracy of minipad collected menstrual blood versus clinician collected cervical samples to test for human papillomavirus (HPV) in the detection of cervical ...

The American Cancer Society is endorsing the use of self-swab kits to test for HPV, because they may reduce barriers to cervical cancer screening. The amended guidelines will "help improve compliance ...

Marlborough, Massachusetts Saturday, February 7, 2026, 12:00 Hrs [IST] ...

Detailed price information for Boston Scientific Corp (BSX-N) from The Globe and Mail including charting and trades.

Discover essential insights on cervical cancer prevention for Indian women, emphasizing early vaccination, hygiene, and ...

Hologic, Inc. (Nasdaq: HOLX) announced today that its Aptima ® HPV Assay received FDA approval for clinician-collected HPV primary screening. Hologic’s human papillomavirus (HPV) test is the only ...